The study of microbial communities has revolutionized our understanding of human health, agricultural productivity, and environmental ecosystems. At the core of this revolution lies 16S ribosomal RNA (rRNA) gene sequencing, a highly targeted phylogenetic marker gene approach utilized to profile complex bacterial populations. However, traditional 16S sequencing protocols typically require substantial starting genomic DNA (gDNA) templates, often in the range of 10 to 100 nanograms. In real-world research and industrial applications, investigators frequently encounter "low-input" or "low-biomass" samples. These are samples where microbial DNA is present in trace quantities, often contaminated by overwhelming host genetic material.
Low-input sample solution framing addresses this critical bottleneck. By optimizing extraction efficiency, minimizing sample loss during library preparation, and employing ultra-sensitive amplification techniques, modern molecular biology can now extract high-fidelity taxonomic profiles from samples containing less than 1 nanogram of bacterial DNA. This technological evolution expands the horizons of metagenomics into previously inaccessible biological niches.
"Framing robust solutions for low-input 16S rRNA sequencing requires a meticulous balance of contamination control, high-efficiency enzymatic amplification, and state-of-the-art bioinformatics tools to successfully separate biological signals from background noise."
The commercial demand for low-input 16S rRNA sequencing is scaling rapidly. In the pharmaceutical sector, microbiome-targeted drug discovery and clinical trials require profiling of low-biomass niches, such as the lung, blood, and tumor microenvironments. Previously, these tissues were considered sterile; however, recent oncology research highlights the presence of distinct tumor-associated microbiomes that can affect therapeutic efficacy.
Industrially, cleanroom monitoring in aerospace and semiconductor manufacturing relies heavily on low-input sequencing. Space exploration agencies must ensure that spacecraft sent to other celestial bodies do not carry Earth-based microbial contaminants—a protocol known as planetary protection. Monitoring these ultra-clean facilities requires analyzing surfaces with extremely low microbial density. Similarly, in the food and beverage industry, monitoring microbial biofilms on processing equipment helps prevent early-stage contamination before pathogens reach levels detectable by traditional culture methods.
Enabling taxonomic profiling from needle biopsies, fine-needle aspirates, and low-yield clinical biofluids.
Analyzing airborne microbiomes, glacial ice cores, and deep sub-surface geological strata with precision.
Unlocking microbial trace evidence from touch DNA samples and decomposing remains for forensic intelligence.
Working with low-input samples introduces unique challenges that do not affect high-biomass samples:
Biomarker Technologies (BMKGene) has developed a comprehensive, standardized workflow to overcome these challenges. Our solution frames the entire process from extraction to bioinformatic analysis under strict quality control standards.
Using our proprietary TGuide Smart Magnetic extraction system, we maximize the recovery of high-purity gDNA while minimizing volume loss. The magnetic bead chemistry is optimized to capture low-molecular-weight fragments typical of degraded or low-abundance environmental samples.
We employ cleanroom library preparation protocols utilizing enzymatically decontaminated PCR reagents. By introducing unique molecular identifiers (UMIs) and utilizing optimized low-cycle amplification, we minimize PCR duplication artifacts and chimera generation. Standard inclusion of negative extraction and negative PCR controls allows for computational subtraction of background contamination during downstream analysis.
Our facility features state-of-the-art platforms, including the Illumina NovaSeq and BGI DNBSEQ systems for short-read, high-depth V3-V4 hypervariable region profiling. For full-length 16S rRNA sequencing (V1-V9), we leverage PacBio Sequel II and Oxford Nanopore PromethION platforms, enabling species-level taxonomic resolution even from limited starting materials.
Biomarker Technologies (BMKGene), founded in 2009, is a leading genomics service provider with over 16 years of continuous innovation in high-throughput sequencing and bioinformatics. Backed by more than 60 national invention patents and 200+ software copyrights, we deliver comprehensive multi-omics solutions—spanning genomics, metagenomics, epigenetics, single-cell omics, transcriptomics, and our proprietary BMKMANU S3000 spatial transcriptome technology—supported by our advanced BMKCloud bioinformatics platform. We have established long-term collaborations with organizations across 84 regions worldwide, providing reliable genomic solutions on a global scale.
Our sequencing center is equipped with a diverse suite of advanced platforms to meet varying research and industrial requirements:
Spanning over 20,000 square feet, our laboratory features advanced biomolecular instruments and standard molecular biology facilities:
Our self-developed BMKCloud platform provides researchers with a reliable, easy-to-use online portal for bioinformatics analysis:
To scale library construction while maintaining the highest quality standards, Biomarker Technologies (BMKGENE) and PerkinElmer have jointly built a fully automated experimental production line: the Brilliant Lab 1000 (BL1000). This system is designed specifically for high-throughput NGS library construction services.
Through the BL1000, BMKGENE significantly increases throughput, reduces delivery times, and enhances overall library consistency, ensuring that even low-input samples are processed with minimal contamination risk.
The ability to extract biological insights from trace microbial samples has unlocked new fields of research:
Historically, tumor tissues were assumed to be sterile. Recent studies have demonstrated that intratumoral bacteria are prevalent across multiple cancer types. These bacteria reside intracellularly within cancer cells and immune cells, shaping the tumor microenvironment and influencing chemotherapy and immunotherapy outcomes. Because tumor biopsies are small and host human DNA dominates the sample, low-input 16S sequencing solutions are critical to characterize these low-abundance microbial populations without sacrificing precious clinical tissues.
The atmosphere acts as a transport medium for bacteria, fungi, and viruses. Understanding the air microbiome is vital for tracking airborne pathogens, agricultural diseases, and studying climate impacts, as some bacteria act as cloud condensation nuclei. Collecting microbial biomass from air samples involves filtering large volumes of air, often yielding low DNA concentrations. Optimized low-input sequencing allows for sensitive, longitudinal profiling of municipal air quality and agricultural biosecurity.
Planetary protection regulations mandate that spacecraft sent to Mars, Europa, or other planetary bodies do not export Earth microbes. Cleanrooms where these probes are assembled are subjected to rigorous swabbing and vacuum sampling. The resulting samples contain minimal biomass. Framing a reliable low-input 16S rRNA sequencing pipeline is essential to identify hardy extremophiles capable of surviving sterilization procedures and potential space travel.
Every individual sheds millions of skin cells and associated microbes onto surfaces they touch. In forensic investigations, trace human DNA may be insufficient for traditional STR profiling. However, the unique personal signature of the skin microbiome left on objects (such as keyboards, doorknobs, or clothing) can serve as complementary trace evidence. Low-input 16S sequencing enables investigators to profile these micro-traces, aiding in human identification and post-mortem interval (PMI) estimation.
BMKGene maintains the highest industry standards for quality control, environmental management, and occupational health. Our extensive portfolio of certifications and patents reflects our commitment to delivering precise, reproducible genomic data.
For inquiries about our products, workflows, or custom price lists, reach out to our technical team. We will get back to you within 24 hours.
Inquiry Now